Comments (1)
-
Heather Fraser
Insightful read
Under NCATS’ leadership, the Clinical and Translational Science Awards (CTSA) Program supports a national network of medical research institutions — called hubs ― that work together to improve the translational research process to get more treatments to more patients more quickly. The hubs collaborate locally and regionally to catalyze innovation in training, research tools and processes.
CTSA Program support enables research teams including scientists, patient advocacy organizations and community members to tackle system-wide scientific and operational problems in clinical and translational research that no one team can overcome. Program goals are to:
While the definitions of basic and clinical research are clear, the definition of translational research is not.
Up until recently, translational science has been about helping investigators get their ideas, inventions and discoveries from "bench to bedside", or translating medical best practices into communities. However, given the drivers of innovation, they now are enabling investigators to take the next steps in taking their discoveries from the bedside to the boardroom i.e. creating commercial and business entities. Doing so, however, requires an academic ecosystem that recruits, educates and trains, develops and promotes faculty clinical translational scientist entrepreneurs (CTSEs) as part of an entrepreneurial university and medical school.
Strategies and tactics to reach that goal should include:
Clinical translational science does not stop at the bedside and end with publishing the results of clinical trials. We need to incorporate clinical translational science entrepreneurship into CTSA programs to give faculty the tools they need to scale and leverage their skills to create even more clinical impact.
Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs.
Insightful read
Leave your comments
Post comment as a guest